ANNOVIS BIO INC. COMMON STOCK
1.4700
22-April-25 20:30:00
15 мин. задержка
Акции
+0.1200
+8.89%
Сегодняшний диапазон
1.4000 - 1.5900
ISIN
N/A
Источник
NYSE
- Котировки
- Графики
Новости
- Статистика
-
30 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference
05 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update
15 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist
06 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap
24 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
16 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
09 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
02 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
27 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
26 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
25 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
18 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
11 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Annovis Announces New Publication in a Peer-Reviewed Journal
21 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
13 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
09 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
06 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
29 апр 2024 10:10:00 Источник Nasdaq GlobeNewswire
-
02 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
01 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire